Asia · General news · The Japan Times

Health ministry questions reliability of vasculitis drug approval data

Published by The Japan Times · Japan 1 h ago

Tavneos was launched in Japan in 2022 after being approved by the ministry. Its package insert listed liver dysfunction as a serious side effect.

Read the full article on The Japan Times Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.japantimes.co.jp)

Also worth reading

Philippine Daily Inquirer

Wrong anthems played at Asian Para Games

Chinese-linked hackers compromise ConnectWise, target hundreds in global attack

VnExpress International

Saigon River's palm-leaf-shaped pedestrian bridge completes final span ahead of 2027 opening

North Korea's Kim Yo Jong warns South Korea, says border loudspeakers to be ready within days

Hindustan Times

In 2018, DNA from wild canines on a Texas island revealed genes from red wolves, a species declared extinct in the wild nearly four decades earlier

Takaichi’s next vote is in the bond market